INS and metabolic syndrome: Daily injections of irisin over 8 weeks ameliorated development of the OVX/HFD-induced MetS phenotype, including improvements in obesity, energy expenditure, insulin sensitivity and lipid profile in comparison with OVX/HFD controls.